Skip to content
Mafenide
Sulfamylon (mafenide) is a small molecule pharmaceutical. Mafenide was first approved as Sulfamylon on 1982-01-01. It is used to treat bacterial infections and wound infection in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
Trade Name
FDA
EMA
Sulfamylon (generic drugs available since 2017-07-31)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Mafenide acetate
Tradename
Company
Number
Date
Products
SULFAMYLONRising PharmaceuticalsN-016763 RX1982-01-01
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
mafenide acetateANDA2017-10-26
sulfamylonNew Drug Application2021-05-18
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
bacterial infections—D001424A49
wound infection—D014946—
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D06: Antibiotics and chemotherapeutics for dermatological use
— D06B: Chemotherapeutics for topical use
— D06BA: Sulfonamides, topical
— D06BA03: Mafenide
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMAFENIDE
INNmafenide
Description
Mafenide (INN; usually as mafenide acetate, trade name Sulfamylon) is a sulfonamide-type medication used as an antibiotic. It was approved by the FDA in 1948.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
NCc1ccc(S(N)(=O)=O)cc1
Identifiers
PDB—
CAS-ID138-39-6
RxCUI6572
ChEMBL IDCHEMBL419
ChEBI ID6633
PubChem CID3998
DrugBankDB06795
UNII ID58447S8P4L (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 499 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
53 adverse events reported
View more details